Pure Global

Beta Human Chorionic Gonadotropin (Beta Human Chorionic Gonadotropin ) - India CDSCO Medical Device Registration

Beta Human Chorionic Gonadotropin (Beta Human Chorionic Gonadotropin ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000104_c663bc724ee033b9fb40e9aa760be837_13b5668083c24479482c5e77bfd3a17a. This device is marketed under the brand name CLIA. The license holder is M/s. Peerless Biotech Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Beta Human Chorionic Gonadotropin (Beta Human Chorionic Gonadotropin )
UID: IMP/IVD/2023/000104_c663bc724ee033b9fb40e9aa760be837_13b5668083c24479482c5e77bfd3a17a

Brand Name

CLIA

Device Class

Class B

Approving Authority

CDSCO

Product Information

Beta Human Chorionic Gonadotropin (CLIA) is a Chemiluminescence Immunoassay test for the quantitative measurement of circulating Beta Human Chorionic Gonadotropin (CLIA) in human serum or plasma, which is intended as an aid to diagnosis of ectopic pregnancy and early pregnancy

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing